MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$1,405,077
EPS
-$0.38
Unit: Dollar

Income Statement
2026-03-31
2025-09-30
2025-06-30
2024-09-30
Revenues
0 0 0 -
Cost of revenues
0 0 0 -
Gross profit
0 0 0 -
Research and development
541,658 465,154 501,261 581,796
Selling, general and administrative
888,640 776,821 731,517 498,607
Amortization of patent costs
28,855 31,059 30,742 29,271
Total expenses
1,459,153 1,273,034 1,263,520 1,109,674
Operating loss
-1,459,153 -1,273,034 -1,263,520 -1,109,674
Interest income
55,436 37,100 30,217 69,539
Total other income
55,436 37,100 30,217 69,539
Loss before provision for income taxes
-1,403,717 -1,235,934 -1,233,303 -1,040,135
Provision for income taxes
0 0 0 -
Net loss
-1,403,717 ---
Net income attributable to non-controlling interest
1,360 ---
Net loss attributable to cmth
-1,405,077 -1,235,934 -1,233,303 -1,040,135
Diluted EPS
-0.38 -0.48 -0.48 -
Diluted Average Shares
3,701,668 2,580,532 2,580,532 -
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to cmth-$1,405,077 Net loss-$1,403,717 Net incomeattributable to...$1,360 Interest income$55,436 Loss beforeprovision for income taxes-$1,403,717 Total other income$55,436 Operating loss-$1,459,153 Total expenses$1,459,153 Selling, general andadministrative$888,640 Research and development$541,658 Amortization of patent costs$28,855

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)